Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know

摘要

Chimeric antigen receptor T-cell therapy is an exciting and rapidly emerging fifth pillar treatment for hematologic cancers. Unique treatment-related toxicities and cost remain a major hindrance to its widespread application. The commonly faced challenges with this innovative therapy, its neurotoxicity, and manifestation on neuroimaging studies, are reviewed.